LSLizhi Shen

Lizhi Shen

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Lizhi Shen has a total of 8 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Research On Palmprint Recognition Based On Mechanism And Data

    by Rongyuan Chen, Yangfan Tang, Yanrong Zhong, Yuanxing Shi, Shaonian Huang, Lizhi Shen

    Among the existing palmprint recognition technologies, traditional methods cannot adaptively extract multi-level features of palmprint images to better represent image information, and methods based on deep learning fail to make full use of prior knowledge existing in palmprint images. To solve this problem, A palmprint recognition method was proposed based on fusion mechanism and data, and constructs a palmprint recognition data model based on deep learning. The prior knowledge in palmprint images is extracted and added to the data model as mechanism knowledge to improve the model's ability to discriminate palmprint features. The multi-direction Gabor filter is used to optimize the prediction results and improve the recognition performance. The experimental results show that the recognition accuracy of the proposed method on CASIA palmprint database is 99.41%, which is better than the existing mainstream methods.


  • Open Access

    Optimal Modeling of Anti-Breast Cancer Candidate Drugs Based on Graph Model Feature Selection

    by Rongyuan Chen, Zhixiong He, Shaonian Huang, Lizhi Shen, Xiancheng Zhou

    Breast cancer is one of the most widespread and fatal cancers in women. At present, anticancer drug-inhibiting estrogen receptor subtype (ER) can greatly improve the cure rate for breast cancer patients, so the research and development of this kind of drugs are very urgent. In this paper, the problem of how to screen excellent anticancer drugs is abstracted as an optimization problem. Firstly, the graph model is used to extract low-dimensional features with strong distinguishing and describing ability according to various attributes of candidate compounds, and then, kernel functions are used to map these features to high-dimensional space. Then, the quantitative analysis model of ER biological activity and the classification model based on ADMET properties of the support vector machine are constructed. Finally, sequential least square programming (SLSQP) is utilized to solve the ER biological activity model. The experimental results show that for anticancer data sets, compared with principal component analysis (PCA), the error rate of the graph model constructed in this paper is reduced by 6.4%, 15%, and 7.8% on mean absolute error (MAE), mean squared error (MSE), and root mean square error (RMSE), respectively. In terms of classification prediction, compared with principal component analysis (PCA), the recall and precision rates of this method are enhanced by 19.5% and 12.41%, respectively. Finally, the optimal biological activity value (IC50_nM) 34.6 and inhibitory biological activity value (pIC50) 7.46 were obtained.